All trials experience roadblocks
Alethium clears the way
Consent with Ease
eCOA for Global Studies
Integrated Video for Modern Trials
Why Us?
Innovation Born from Experience
Advancing Breakthrough Research
From vaccines to groundbreaking research in Multiple Sclerosis, Oncology, NASH, Chikungunya, Cardiology, Vaccine/Infectious Diseases, Hepatitis B, and Ophthalmology, Alethium has tackled some of the toughest trails for the world’s leading CROs and sponsors.
Cardiology
Neurology
Ophthalmology
Oncology
Vaccine
Virology
Phase 1
Phase 2
Phase 3
Phase 4
Flexible Design
Further Alethium conforms to your protocol’s needs rather than forcing your protocol into a strict pre-determined model. Unlike rigid top-down structures, Alethium models trial protocols from the bottom up, tailoring them to your specific requirements.
A Team Like No Other
Since our establishment in 2008, we have solved our clients' most formidable challenges with a combination of expertise, trust, and diligence. Our team operates with the efficiency and cohesion born from years of collaboration, reflected in our refined processes, streamlined communication, and the exceptional quality of the solutions.
Risk-Based Architecture
Alethium’s event-driven architecture is the core of our trial platform. This paradigm places the audit log at the center of your trial and guarantees absolute audit log accuracy, reducing risk, streamlining audits, and speeding trial completion.
Clarity and Collaboration
Behavior-driven Development (BDD) is the cornerstone of Alethium’s development processes. It produces meticulous, flexible, and accessible living documentation for seamless team alignment. BDD ensures thorough feature vetting, preemptive issue resolution, and precise example crafting for effective development and testing. These examples, doubling as automated tests, inform Alethium’s trace matrix and customer documentation.